Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG434881 Inhibitors

EG434881 inhibitors are a class of chemical compounds specifically developed to inhibit the activity of the EG434881 protein, a molecule involved in key cellular functions such as signal transduction, enzymatic regulation, and cellular homeostasis. EG434881 is thought to play a role in controlling specific metabolic and signaling pathways by facilitating interactions between proteins or participating directly in catalytic processes. The inhibitors of EG434881 are designed to bind selectively to crucial regions of the protein, such as the active site or specific regulatory domains, to block its activity effectively. These inhibitors can work by occupying the site where natural substrates or cofactors would normally bind, thereby preventing the protein from executing its role, or by binding to an allosteric site that induces structural changes, resulting in reduced protein activity. The goal of developing these inhibitors is to achieve a high degree of specificity for EG434881, ensuring minimal interaction with other proteins and avoiding unintended effects on related cellular pathways.

The development of EG434881 inhibitors involves advanced structural biology and computational techniques to understand the protein's architecture and how it can be effectively targeted. Techniques like X-ray crystallography, cryo-electron microscopy (cryo-EM), and nuclear magnetic resonance (NMR) spectroscopy provide detailed information about the three-dimensional structure of EG434881, revealing key features such as binding pockets and regions essential for function. This information is used to design and optimize inhibitors through computational methods, such as molecular docking and molecular dynamics simulations, which predict how potential inhibitors will interact with EG434881 and refine their binding affinity and specificity. Structure-activity relationship (SAR) studies play an essential role in optimizing these inhibitors, allowing researchers to systematically modify chemical groups and assess their impact on efficacy. The chemical structures of EG434881 inhibitors often include functional groups that enhance their ability to interact specifically with the protein, such as aromatic rings for π-π interactions, polar groups for hydrogen bonding, or hydrophobic regions that complement the protein's surface. These inhibitors can range in complexity from small organic molecules that precisely fit into the active site to more elaborate compounds that engage multiple regions of the protein. The successful development of EG434881 inhibitors is based on a combination of structural insights, chemical synthesis, and iterative optimization, aiming to precisely modulate the activity of EG434881 and contribute to the understanding of its role in cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Rho-associated protein kinase (ROCK) inhibitor influencing cytoskeletal dynamics. Y-27632 might indirectly impact Samt2 by modulating cell adhesion through ROCK signaling, which is involved in tight junction assembly and maintenance at the plasma membrane.

PF-562271

717907-75-0sc-478488
sc-478488A
sc-478488B
5 mg
10 mg
50 mg
$312.00
$474.00
$1124.00
3
(1)

Focal adhesion kinase (FAK) inhibitor influencing cell adhesion and migration. PF-562271 might indirectly affect Samt2 by targeting FAK signaling, disrupting processes related to bicellular tight junction assembly and cell adhesion at the plasma membrane.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

Myosin light chain kinase (MLCK) inhibitor influencing cytoskeletal dynamics. ML-7 may indirectly impact Samt2 by modulating MLCK-mediated processes, including cell adhesion and tight junction assembly, affecting its predicted functions at the plasma membrane.

(±)-Blebbistatin

674289-55-5sc-203532B
sc-203532
sc-203532A
sc-203532C
sc-203532D
5 mg
10 mg
25 mg
50 mg
100 mg
$183.00
$313.00
$464.00
$942.00
$1723.00
7
(1)

Myosin II inhibitor affecting cytoskeletal dynamics. Blebbistatin could indirectly inhibit Samt2 by disrupting myosin II-dependent processes involved in bicellular tight junction assembly and cell adhesion at the plasma membrane.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

Transforming growth factor-beta receptor (TGF-βR) inhibitor affecting cell adhesion. SB-431542 might indirectly impact Samt2 by modulating TGF-βR signaling, influencing processes related to bicellular tight junction assembly and plasma membrane-associated cell adhesion.

GSK 269962

850664-21-0sc-363279
sc-363279A
10 mg
50 mg
$300.00
$1000.00
1
(0)

ROCK and MRCK (myotonic dystrophy-related Cdc42-binding kinases) inhibitor affecting cytoskeleton. GSK269962A may indirectly inhibit Samt2 by targeting ROCK and MRCK signaling, disrupting processes related to tight junction assembly and cell adhesion at the plasma membrane.

EHop-016

1380432-32-5sc-497382
5 mg
$80.00
(0)

Rac GTPase inhibitor influencing cytoskeletal dynamics. EHop-016 might indirectly impact Samt2 by modulating Rac GTPase-dependent processes involved in bicellular tight junction assembly and plasma membrane-associated cell adhesion.